Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Vanni

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
International Journal of Molecular Sciences|November 13, 2021
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult RhabdomyosarcomasAlessandro De Vita, Silvia Vanni, Valentina Fausti, et al.
Biomaterials Advances|July 1, 2026
Drug-loaded biomorphic scaffolds for tissue regeneration and targeted antitumor therapy in bone metastasis modelsClaudia Cocchi, Valentina Bergamini, Monica Montesi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Critical Reviews in Oncology/Hematology|September 25, 2025
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma GroupLorenzo D'Ambrosio, Marta Sbaraglia, Alessandra Merlini, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
International Journal of Molecular Sciences|November 13, 2021
Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult RhabdomyosarcomasAlessandro De Vita, Silvia Vanni, Valentina Fausti, et al.
Biomaterials Advances|July 1, 2026
Drug-loaded biomorphic scaffolds for tissue regeneration and targeted antitumor therapy in bone metastasis modelsClaudia Cocchi, Valentina Bergamini, Monica Montesi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Critical Reviews in Oncology/Hematology|September 25, 2025
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma GroupLorenzo D'Ambrosio, Marta Sbaraglia, Alessandra Merlini, et al.
Pageof 5